ASPG and sarcoma: As complex 1 inhibitors significantly augmented the adverse effects of asparagine depletion of mouse sarcoma cells (Figure 6), human RD cells were exposed to combinatorial treatment with asparaginase and phenformin (Figure 7d–f).